Journal article

Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy

JOB Hourihane, KJ Allen, WG Shreffler, G Dunngalvin, JA Nordlee, GA Zurzolo, A Dunngalvin, LC Gurrin, JL Baumert, SL Taylor

Journal of Allergy and Clinical Immunology | MOSBY-ELSEVIER | Published : 2017

Abstract

Background Eliciting doses (EDs) of allergenic foods can be defined by the distribution of threshold doses for subjects within a specific population. The ED05 is the dose that elicits a reaction in 5% of allergic subjects. The predicted ED05 for peanut is 1.5 mg of peanut protein (6 mg of whole peanut). Objective We sought to validate the predicted peanut ED05 (1.5 mg) with a novel single-dose challenge. Methods Consecutive eligible children with peanut allergy in 3 centers were prospectively invited to participate, irrespective of previous reaction severity. Predetermined criteria for objective reactions were used to identify ED05 single-dose reactors. Results Five hundred eighteen children..

View full abstract

University of Melbourne Researchers